Quantum Pharma

Calibrated on 1,601 real IBM Heron jobs — not simulation.

Kill the bad molecule early.

Most drug candidates fail — and the later they fail, the more they cost. Quantum Pharma runs the classical pre-screens that wash out the non-starters fast, then escalates the heavy steps only when a survivor earns it. Every screen is sealed.

The problem we exist to solve

Nine in ten candidates fail.
The expensive ones fail last.

  • Failure in the clinic costs billions A molecule that washes out in Phase II took years and a fortune to get there. The cheapest failure is the one you catch at the bench.
  • The search space is astronomical There are more drug-like molecules than atoms in the solar system. You can't synthesize your way through it — you have to screen first.
  • Regulators want the trail Every screen, every decision, needs to stay inspectable. A result you can't re-derive is a result a regulator won't accept.

What it screens

Screen, predict,
optimize, fold.

Classical pre-screens first. Quantum lead-optimization when escalation is earned — not before.

  • Candidate & virtual screening Wash out the non-starters fast — drug-likeness, virtual screening, ADMET safety prediction at the bench.
  • Lead optimization Improve the survivors — lead optimization and binding-affinity estimation against the target.
  • Structure Conformer search, protein-folding simulation and de-novo generation — the shapes that make or break a fit.
  • Safety & genomics Drug-drug interaction analysis and genomic-variant screening — the safety signals that matter before the clinic.

The discovery bench

Profile a candidate. Seal the verdict.

A working pre-screen bench. Enter a molecule's descriptors and it checks Lipinski's Rule of Five and Veber's rules, plots each property against its limit, flags the ADMET liabilities, and seals the screen — the deterministic gate that decides what's worth escalating.

Descriptors · Lipinski · Veber

Lipinski Ro5 · VeberDrug-like
0 violations
In-browser demonstration. Deterministic RDKit-style pre-screen, sealed locally with WebCrypto SHA-256. Local illustration — not a live quantum run.

How a screen is made

Pre-screen. Optimize.
Seal.

  1. Classical gate

    Rules wash out the molecules that can't be oral drugs — fast, deterministic, recomputable by hand.

  2. Escalate when earned

    Survivors go to lead optimization and binding-affinity estimation. Real quantum only when the job earns it.

  3. Sealed for audit

    Every screen gets a signature and watermark on a tamper-evident record. A third party can verify it without taking our word for it.

Built for audit

Every screen
gets sealed.

Signature and watermark on by default — written so compliance can open the trail later. Sealing is enforced; you don't turn it on after the fact.

Open a discovery run

Walk a live fold-to-binding pass, or send a target and we will run it.